Ablation Devices Market Research Report by Type, Function, Technology, Application, End-use, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19 – Yahoo Finance
The Global Ablation Devices Market size was estimated at USD 6,183. 53 million in 2021 and expected to reach USD 6,903. 30 million in 2022, and is projected to grow at a CAGR 11. 89% to reach USD 12,136.
New York, Jan. 02, 2023 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Ablation Devices Market Research Report by Type, Function, Technology, Application, End-use, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p06335705/?utm_source=GNW
69 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Ablation Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Cryoablation Devices, Electrical Ablators, Hydrothermal/Hydromechanical Ablators, Laser/Light Ablators, Microwave Ablators, Radiofrequency Ablators, and Ultrasound Ablators.
Based on Function, the market was studied across Automated and Conventional.
Based on Technology, the market was studied across Cryoablation Devices, Laser/Light Ablation, Radiofrequency Devices, and Ultrasound Devices.
Based on Application, the market was studied across Cancer Treatment, Cardiovascular Disease Treatment, Cosmetic/ Aesthetic Surgery, Gynecological Treatment, Ophthalmologic Treatment, Orthopedic Treatment, Pain Management, and Urological Treatment.
Based on End-use, the market was studied across Ambulatory Surgical Centers and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Ablation Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Ablation Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Ablation Devices Market, including Abbott Laboratories, Alcon Vision LLC, AngioDynamics, Inc., Arthrex, Inc, Atricure, Inc., Bausch & Lomb Incorporated, Biotronik SE & Co. KG, Boston Scientific Corporation, Conmed Corporation, Cynosure, LLC, Elekta AB, Ethicon, Inc. (Johnson & Johnson), IceCure Medical Ltd., Inmode Group, Lumenis Be Ltd., Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Smith & Nephew PLC, Stryker Corporation, and Varian Medical Systems, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Ablation Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ablation Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ablation Devices Market?
4. What is the competitive strategic window for opportunities in the Global Ablation Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Ablation Devices Market?
6. What is the market share of the leading vendors in the Global Ablation Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Ablation Devices Market?
Read the full report: https://www.reportlinker.com/p06335705/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Lupin Pharmaceuticals Inc. voluntarily recalled four lots of blood pressure medication Quinapril after concerns they might have more than the accepted daily intake level of nitrosamine impurity, N-Nitroso-Quinapril, which may increase the risk of cancer. "Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Dail
Hugh Freeze and staff are continuing to work towards building the best OL in the SEC by offering talented options from the transfer portal.
The 98-year-old investing legend has spoken.
The first phenomenal stock that has the potential to deliver triple-digit returns for its shareholders in the new year is biotech stock Novavax (NASDAQ: NVAX). Since hitting its all-time high during the COVID-19 pandemic, shares of Novavax have plunged as much as 97%. Novavax is one of a handful of drug developers that earned acclaim by running clinical trials for a COVID-19 vaccine.
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has a knack for outperforming Wall Street. This outperformance was on display, once again, during the 2022 bear market. Whereas the S&P 500 lost 19%, not including dividends paid, last year, Berkshire Hathaway's share price advanced 4%.
The Oracle of Omaha won't even buy one share of a company if it doesn't meet this criterion.
Two top-notch dividend stocks, with yields of 7.2% and 8%, are ripe for the picking, while another income stock with a yield of nearly 70% could be in for a rough year.
Dow Jones futures kick off the 2023 stock market after a "stay away" year. Q4 Tesla deliveries hit a record, but missed lowered views again.
Thirty-one percent year-over-year growth from the electric-car maker wasn't enough to match analysts' consensus forecast for the quarter.
The conventional wisdom is saying that after the high inflation and severe market losses of 2022, we’re in for a rough ride going forward. But there are always contrarian voices, giving alternate opinions and predictions – and that’s what we’re getting from Jonathan Golub, chief U.S. equity strategist at Credit Suisse. Golub’s point is based on data. As he sees it, “The data looks a lot less recessionary that it did three or four months ago… The things [consumers] buy aren't going to go up as
General Electric (NYSE: GE) is a value situation with the potential to surprise on the upside. United Parcel Service (NYSE: UPS) stock has been sold off due to near-term concerns, but underlying improvements in its business enhance its long-term earnings generation potential. Hexcel's (NYSE: HXL) composites are the future of the aerospace industry.
While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Investors can get 3% to 5% yields on municipal bonds, 8% to 9% yields on junk debt, 6% to 8% on preferred stock, and 4% on risk-free short-term Treasuries. Within the stock market, there are yields of 5% to 9% on pipeline companies, 6% on telecom operators, 4% on real estate investment trusts, and 3% on utilities and a broad group of dividend-paying companies, including big banks.
With the help of a cohort of first-time African American hotel investors, the two were able to acquire the 70-room property located in the Raleigh neighborhood part of the city for $3.85 million.
In this article, we will take a look at Ken Fisher’s top 15 growth stock picks. If you want to see more stocks in this selection, go to Ken Fisher’s Top 5 Growth Stock Picks. The founder of Fisher Asset Management, Ken Fisher, believes that the market circumstances in 2023 will be similar to those […]
Tesla's deliveries in the fourth quarter set a record but miss analysts' expectations; Chinese electric-vehicle makers NIO, XPeng, and Li Auto report strong deliveries for December.
FCF is what's left over from net income after working capital requirements and capital expenditures have been taken out. It's the flow of cash in a year that can be used to make returns to investors (through dividends and share buybacks), fund acquisitions, or, as in Boeing's case, pay down debt. FCF should be a crucial focus for Boeing investors because it's gone south in recent years.
If you really want to rev up your retirement savings and minimize income taxes, the best thing to be is a late-career professional in private practice. When you’re making a lot of money and are close to retirement age, you have savings options that go way beyond the levels of the typical workplace 401(k) plan. As long as you can handle a little extra paperwork and some fees, you can set up a solo retirement plan and enjoy higher limits than most employees.
Shares of Chinese electric-vehicle makers rose Tuesday in Hong Kong, led by Li Auto Inc., after strong December delivery data.
(Bloomberg) — Tesla Inc. delivered fewer vehicles than expected last quarter despite offering hefty incentives in its biggest markets, reinforcing demand concerns that contributed to the worst month and year for the electric-car maker’s stock since its 2010 initial public offering.Most Read from BloombergElon Musk Becomes First Person Ever to Lose $200 BillionChina’s Foreign Minister Says ‘Deeply Impressed’ With AmericansUkraine Latest: Strike Kills 63 Russian Troops in Occupied TownXi Warns of
(Bloomberg) — The fallout from the collapse of Sam Bankman-Fried’s crypto empire just got messier, with digital-asset entrepreneur Cameron Winklevoss accusing fellow businessman Barry Silbert of “bad faith stall tactics” and the intermingling of funds within his conglomerate that Winklevoss says have left $900 million in customer assets needlessly in limbo since FTX’s meltdown.Most Read from BloombergElon Musk Becomes First Person Ever to Lose $200 BillionChina’s Foreign Minister Says ‘Deeply I